Why the study?
Does antiplatelet therapy prevent death, myocardial infarction, and stroke in high risk patients?
Does antiplatelet therapy prevent death, myocardial infarction, and stroke in high risk patients?
Low dose aspirin (75-150 mg daily) is an effective long-term antiplatelet regimen for preventing occlusive vascular events in high-risk patients, with higher loading doses required in acute settings.
No takes yet. Share an insight, caveat, or question.
Supports routine antiplatelet use in high-risk patients; confirms broad efficacy across trial populations.
Antiplatelet Trialists Collaboration (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: